IP Library Granted Patent US 7,407,480
Granted Patent B2
US 7,407,480 · App. 10/423,662 · Granted Aug 5, 2008

Method and apparatus for correction of urinary and gynecological pathologies, including treatment of incontinence cystocele

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,407,480
App. No.
10/423,662
Granted
Aug 5, 2008
Kind
B2
Abstract

Surgical articles, implants and components suitable for female pelvic health procedures are described.

Claims (50)

1. A surgical kit comprising an insertion tool and an implant for addressing incontinence and cystocele disorders, the implant comprising:

a cystocele repair portion adapted to be secured in the patient's vaginal region, comprising a major portion that is sized and shaped to afford repair of a cystocele without lifting the patient's bladder and without placing tension on the bladder, the major portion including a urethral support portion capable of being placed underneath the patient's urethra;

a first posterior securement appendage that is sized, shaped and configured to extend from the patient's vaginal region toward a first incision in the patient's buttocks that is lateral to the patient's anus;

a second posterior securement appendage that is sized, shaped and configured to extend from the patient's vaginal region, on a side of the patient's anus different than that of the first posterior securement appendage, toward a second incision in the patient's buttocks that is on a side of the patient's anus opposite the first incision;

a first sling appendage for securement on a first side of the patient's urethra; and

a second sling appendage for securement on a side of the patient's urethra generally opposite the first side of the urethra;

wherein one or more of the first posterior securement appendage, the second posterior securement appendage, the first sling appendage, and the second sling appendage, includes a connector configured to engage a distal end of an insertion needle;

the insertion tool comprising a proximal end and a distal end, a handle at the proximal end, and the distal end being configured to engage the connector; and

wherein the mesh material comprises bulk knitted polypropylene monofilaments, and bulk material from which the mesh is supplied has at least a Longitudinal Elongation Factor (LEF) of 0.06 under a ½ pound load.

2. A surgical kit comprising an insertion tool and an implant for addressing incontinence and cystocele disorders, the implant comprising:

a cystocele repair portion adapted to be secured in the patient's vaginal region,

a first posterior securement appendage that is sized, shaped and configured to extend from the patient's vaginal region toward a first incision in the patient's buttocks that is lateral to the patient's anus;

a second posterior securement appendage that is sized, shaped and configured to extend from the patient's vaginal region, on a side of the patient's anus different than that of the first posterior securement appendage, toward a second incision in the patient's buttocks that is on a side of the patient's anus opposite the first incision;

the implant including a urethral support portion capable of being placed underneath the patient's urethra;

a first sling appendage for securement on a first side of the patient's urethra; and

a second sling appendage for securement on a side of the patient's urethra generally opposite the first side of the urethra;

wherein one or more of the first posterior securement appendage, the second posterior securement appendage, the first sling appendage, and the second sling appendage, includes a connector configured to engage a distal end of an insertion needle;

the insertion tool comprising a proximal end and a distal end, a handle at the proximal end, and the distal end being configured to engage the connector; and

wherein bulk material from which the mesh is supplied has at least a Longitudinal Elongation Factor (LEF) of more than about 0.08 under a ½ pound load.

3. A surgical implant according to claim 2 wherein bulk material from which the mesh is supplied has at least a Longitudinal Elongation Factor (LEF) of more than about 0.15 under a ½ pound load.

4. A surgical kit comprising an insertion tool and an implant for addressing incontinence and cystocele disorders, the implant comprising:

a cystocele repair portion adapted to be secured in the patient's vaginal region;

a first posterior securement appendage that is sized, shaped and configured to extend from the patient's vaginal region toward a first incision in the patient's buttocks that is lateral to the patient's anus;

a second posterior securement appendage that is sized, shaped and configured to extend from the patient's vaginal region, on a side of the patient's anus different than that of the first posterior securement appendage, toward a second incision in the patient's buttocks that is on a side of the patient's anus opposite the first incision;

the implant including a urethral support portion capable of being placed underneath the patient's urethra;

a first sling appendage for securement on a first side of the patient's urethra; and

a second sling appendage for securement on a side of the patient's urethra generally opposite the first side of the urethra;

wherein one or more of the first posterior securement appendage, the second posterior securement appendage, the first sling appendage, and the second sling appendage, includes a connector configured to engage a distal end of an insertion needle;

the insertion tool comprising a proximal end and a distal end, a handle at the proximal end, and the distal end being configured to engage the connector;

bulk material from which the mesh is supplied has at least a Longitudinal Elongation Factor (LEF) of at least 0.06 under a ½ pound load; and

bulk material from which the mesh is supplied has a Longitudinal Elongation Factor (LEF) of more than about 0.08 under a 1 pound load.

5. A surgical implant according to claim 4 wherein bulk material from which the mesh is supplied has a Longitudinal Elongation Factor (LEF) of more than about 0.1 under a 1 pound load.

6. A surgical implant according to claim 5 wherein bulk material from which the mesh is supplied has a Longitudinal Elongation Factor (LEF) of more than about 0.2 under a 1 pound load.

7. A surgical kit comprising an insertion tool and an implant for addressing incontinence and cystocele disorders, the implant comprising:

a cystocele repair portion adapted to be secured in the patient's vaginal region;

a first posterior securement appendage that is sized, shaped and configured to extend from the patient's vaginal region toward a first incision in the patient's buttocks that is lateral to the patient's anus;

a second posterior securement appendage that is sized, shaped and configured to extend from the patient's vaginal region, on a side of the patient's anus different than that of the first posterior securement appendage, toward a second incision in the patient's buttocks that is on a side of the patient's anus opposite the first incision;

the implant including a urethral support portion capable of being placed underneath the patient's urethra;

a first sling appendage for securement on a first side of the patient's urethra; and

a second sling appendage for securement on a side of the patient's urethra generally opposite the first side of the urethra;

wherein one or more of the first posterior securement appendage, the second posterior securement appendage, the first sling appendage, and the second sling appendage, includes a connector configured to engage a distal end of an insertion needle;

the insertion tool comprising a proximal end and a distal end, a handle at the proximal end, the distal end being configured to engage the connector; and

wherein the connector is a dilating connector.

8. A surgical kit comprising an insertion tool and an assembly for addressing a female patient's pelvic health disorder, the assembly comprising:

a portion adapted to be secured in the patient's vaginal region;

a first posterior securement appendage that is sized, shaped and configured to extend from the patient's vaginal region toward a first incision in the patient's buttocks that is lateral to the patient's anus;

a second posterior securement appendage that is sized, shaped and configured to extend from the patient's vaginal region, on a side of the patient's anus different than that of the first posterior securement appendage, toward a second incision in the patient's buttocks that is on a side of the patient's anus opposite the first incision;

the first and second posterior securement appendages including a connector for associating the first and second posterior securement appendages with a distal end of an insertion needle; and

the insertion tool comprising a handle and a needle, the needle comprising a proximal end extending from the handle and a distal end configured to engage a connector;

wherein the connector is a dilating connector.

Assignments (16)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0491 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2018
From: ASTORA WOMEN'S HEALTH, LLC
To: STASKIN, DAVID, MD, DR
Reel/Frame 045605/0796 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0728. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042308/0630 →
CHANGE OF NAME Recorded Jan 18, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037551/0749 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037551/0626 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0728 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →
RELEASE OF SECURITY INTEREST Recorded Apr 18, 2011
From: CIT HEALTHCARE LLC
To: AMERICAN MEDICAL SYSTEMS, INC.
Reel/Frame 026142/0569 →
SECURITY AGREEMENT Recorded Aug 18, 2006
From: AMERICAN MEDICAL SYSTEMS, INC.
To: CIT HEALTHCARE LLC
Reel/Frame 018132/0639 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2003
From: STASKIN, DAVID R.; ANDERSON, KIMBERLY A.; MONTPETIT, KAREN PILNEY; WESTRUM, JOHN W., JR.; WATSCHKE, BRIAN P.; COX, JAMES E.
To: AMS RESEARCH CORPORATION
Reel/Frame 013778/0679 →